Home›Companies›Biotech & Pharma›Keliomics

Keliomics, Inc.

Updated Oct 29, 2026·Latest SEC filing Nov 30, 2023·Suggest an edit

About Keliomics

Keliomics is a private company based in Portland, Oregon. It has reported $2,275,000 raised in one offering on Form D since October 2022. Its chief executive is Frank Lau.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 26, 2022Oct 11, 2022amended Nov 30, 2023$2,275,000of $7.0M target17$133KDebt, OptionsRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Keliomics's Form D filed Nov 30, 2023.

FL
Frank Lau
Chief Executive Officer and director
JB
Jason Bourgeois
Executive officer and director

Sources

  1. SECKeliomics, Inc. Form D, filed Oct 11, 2022
  2. SECKeliomics, Inc. filing history